๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novozymes in 2004


Book ID
104385544
Publisher
Elsevier Science
Year
2005
Weight
37 KB
Volume
2005
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis


The Exclusive Synthesis & Catalysts business unit of Germany based Degussa AG is setting up a R&D laboratory near Mumbai to carry out contract research for lab and kilo-lab samples and develop syntheses and processes for the Exclusive Synthesis business line during 2005. Degussa will invest โ‚ฌ1 M for Phase I development with the installation of the analytical and kilolab equipment in a 7000 sq ft facility. The company will appoint 15-20 chemists and technicians by the end of 2005. Degussa's Exclusive Synthesis & Catalysts business unit focuses on the custom manufacturing of chemical catalysts, advanced pharmaceutical intermediates, and APIs.


๐Ÿ“œ SIMILAR VOLUMES


Novozymes 1H 2004
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science โš– 47 KB
Novozymes' results 2Q 2004
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science โš– 36 KB

For its fiscal 2004, the Catalysts Division of Johnson Matthey plc has reported turnover of ยฃ1143 M (ยฃ1083 M for its fiscal 2003) and operating profit of ยฃ109.2 M (ยฃ95.3 M). There is a detailed business review, covering: environmental catalysts & technologies, process catalysts & technologies, fuel

Novozymes results up in 1-3Q 2004
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science โš– 36 KB

Johnson Matthey has completed the acquisition of the worldwide business of Lancaster